Interphase FISH studies of chronic myeloid leukemia

GW Dewald - Molecular cytogenetics: protocols and applications, 2003 - Springer
This chapter deals with the application of fluorescence in situ hybridization (FISH) to study
interphase nuclei from patients with chronic myeloid leukemia (CML). In our experience …

Metaphase fluorescence in situ hybridization (FISH) in the follow‐up of 60 patients with haemkopietic malignancies

SJ Nylund, T Ruutu, U Saarinen… - British journal of …, 1994 - Wiley Online Library
Metaphase DNA fluorescence in situ hybridization (metaphase‐FISH) was performed on
follow‐up samples from 60 patients suffering from haemopoietic malignancies (acute and …

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

A Hochhaus, F Lin, A Reiter, H Skladny, PJ Mason… - 1996 - ashpublications.org
Interferon-alpha (IFN-alpha) induces cytogenetic responses of variable degree in patients
with chronic myelogenous leukemia (CML). We sought to establish the relationship between …

Molecular response of CML patients treated with interferon‐α monitored by quantitative Southern blot analysis

A Reiter, H Skladny, A Hochhaus… - British journal of …, 1997 - Wiley Online Library
We analysed 459 samples from 206 chronic myeloid leukaemia (CML) patients at diagnosis
and during or after treatment with interferon‐α (IFN‐α) by quantitative Southern blot analysis …

Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon α therapy?

F Brizard, JC Chomel, A Veinstein, J Rivet, C Giraud… - Leukemia, 1998 - nature.com
Cytogenetic, interphase fluorescent in situ hybridization (FISH) and RT-PCR methods were
used to study minimal residual disease in peripheral blood stem cells collected for …

Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemia

A Amiel, S Yarkoni, M Fejgin, E Gaber, A Nagler… - Cancer genetics and …, 1993 - Elsevier
We describe the use of the fluorescence in situ hybridization (FISH) technique to detect
residual Philadelphia chromosome-positive (Ph+) cells in a patient with blastic phase …

Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M‐BCR positive chronic myeloid leukemia (CML) …

JL Steegmann, MJ Requena, LF Casado… - American journal of …, 1996 - Wiley Online Library
Cytogenetic analysis is the gold standard for the follow‐up of CML patients. The sensitivity of
cytogenetics is fairly similar to that of Southern detection of M‐BCR rearrangement (5%); this …

Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.

T Lion, A Gaiger, T Henn, E Hörth, OA Haas, K Geissler… - Leukemia, 1995 - europepmc.org
Interferon-alpha (IFN-alpha) has become a widely used treatment modality in chronic
myelogenous leukemia (CML) and was shown to induce complete hematologic responses …

Monitoring the Efficiency of Interferon-α Therapy in Chronic Myelogenous Leukemia (CML) Patients by Competitive Polymerase Chain Reaction.

A HOCHHAUS, LIN Feng, A REITER… - Leukemia …, 1997 - search.ebscohost.com
Interferon α (IFN-α) induces cytogenetic responses of variable degree in patients with CML.
We sought to establish the relationship between BCR-ABL transcript numbers measured by …

[引用][C] Near-haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe

D Gancberg, JL Dargent, A Verhest… - Cancer genetics …, 2001 - cancergeneticsjournal.org
The molecular hallmark of chronic myeloid leukemia (CML) is the BCR-ABL fusion gene,
which usually results from at (9; 22). Eighty-five percent of CML cases demonstrate this …